LN:INDV Indivior PLC

Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence worldwide. The company's product candidates focus on treating opioid use disorder, alcohol use disorder, overdose rescue, and CNS disorders/schizophrenia. It markets and promotes SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy analgesic products that include Temgesic, Burpex, and Buprenex. The company was incorporated in 2014 and is headquartered in Richmond, Virginia.This company has ADRs that trade in the U.S. as the symbol INVVY.

1,512.00 GBP
As of 03/08/2023

---

Security Information

---

Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  12/23/2014
Stock exchange:    London Stock Exchange
Exchange country:   United Kingdom
Market cap:   2,212,112,640 GBP
Current dividend yield:   0.00%
Sedol:      BRS65X6